| 5-aza-dC | 5-aza-2’deoxycytidine |
| ADMA | asymmetric dimethyl arginine |
| ALA | 5-aminolevulinic acid |
| Adox | adenosine dialdehyde |
| CCND1 | cyclin D1 |
| CRE | cAMP-responsive element |
| DNMTs | DNA methyltransferases |
| EDC | epidermal differentiation complex |
| ER | estrogen receptors |
| EREs | estrogen response elements |
| ERK | extracellular signal-regulated kinase |
| EZH2 | enhancer of zeste homolog 2 |
| HBV | hepatitis B virus |
| HBx | protein HBV X protein |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| HIF | hypoxia-inducible factor |
| IGF-1 | insulin-like growth factor-1 |
| IL | interleukin |
| JNK | c-Jun N-terminal kinase |
| MAPKs | mitogen-activated protein kinases |
| MEK | MAPK/ERK kinase |
| MMA | monomethyl arginine |
| MMP | matrix metalloproteinase |
| MMSET | multiple myeloma SET domain |
| MT2A | metallothionein 2A |
| PDT | photodynamic therapy |
| PKMTs | protein lysine methyltransferases |
| PRMTs | protein arginine methyltransferases |
| PTMs | post-translational modifications |
| RACO-1 | RING domain AP-1 coactivator-1 |
| SAH | S-adenosylhomocysteine |
| SAM | S-adenosylmethionine |
| SDMA | symmetric dimethylarginine |
| SMYD3 | SET- and MYND-domain containing protein 3 |
| SRC | steroid-receptor coactivator |